Kaylie Jones
May 9, 2016
Related Articles
Mark Pennesi, M.D., Ph.D., FARVO, Director of Ophthalmic Genetics, celebrates first year with the Retina Foundation Voelcker Fund Gives $100,000 in Support of Texas 1000 Project Recently@Retina Newsletter July 2023 Recently@Retina Newsletter March 2024 Promising Results From Ongoing Phase 1/2 Clinical Trial for X-Linked Retinitis Pigmentosa (XLRP)